Behind the Most Exciting Stock Pop in Years
Moderna’s stock is up over 100%.
Mindfully Curated
Moderna’s stock is up over 100%.
Cardiovascular and surgical segments drove 13.7% organic revenue growth.
Flex pump launch drives 15.8% revenue growth and guidance raise.
USA Rare Earth has been making some big moves recently.
There’s no need to rush after IPO stocks.
Both stocks are growing at an unreal pace.
Archer recently made a deal that’s poised to have a transformative impact on the company.
The risk-versus-reward profile for these two beaten-down companies is now highly favorable for patient, opportunistic investors.
Salesforce’s latest quarterly report was a game changer for the stock.
Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity. Combining two types of drugs reversed many of these changes and sharply slowed tumor growth in preclinical experiments, offering…
Bloom Energy has secured a spot in the S&P 500 as part of its quarterly rebalancing.
With crypto prices soaring and ETF inflows accelerating, there are only a few assets that are worth buying right now.
David is beating Goliath this year, but each retailer is packing healthy slingshot ammo.
Alphabet and Meta are taking two different paths in AI.
September has delivered an average decline of more than 1%.
Gartner’s latest quarterly report arrived with news that weakened the bearish narrative surrounding the stock.
A critically endangered roloway monkey has given birth just months after surgeons performed an unusual operation that saved her foot from amputation. Her new daughter, Lagertha, is an important addition to a species believed to number fewer than 2,000 …
A surprising immune system signal may help explain why zebrafish can regenerate damaged spinal cords so effectively. Researchers found that certain neutrophils release Il-4, which calms harmful inflammation and allows injured nerve fibers to grow again…